This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

Litramine in Weight Maintenance

Sponsored by InQpharm Group

About this trial

Last updated 11 years ago

Study ID

INQ/024511

Status

Completed

Type

Interventional

Phase

Phase 4

Placebo

Yes

Accepting

18 to 60 Years
All Sexes

Trial Timing

Ended 14 years ago

What is this trial about?

The effect of Litramine on weight loss has previously been studied during a 12-week intervention period with promising results. The present study looks into the effect of weight maintenance using Litramine following initial weight loss, for a longer period of 24 weeks.

What are the participation requirements?

Inclusion Criteria

* Documented weight loss, achieved over the last 3 to 6 months either from participation in weight loss clinical trials or weight loss regimens, of at least 3% at the point of screening

* BMI 25-35 before initial weight loss

* Documented compliance (according to the investigator's judgement) to previous weight loss clinical trials/ regimens

Exclusion Criteria

* Known sensitivity to the ingredients of the device (citric acid, acacia or Fabaceae family)

* BMI < 18.5

* Presence of other factor(s) that, in the investigator's judgement, should preclude subject participation